Cargando…
L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine
The present study evaluates the use of thiolized chitosan conjugates (CS) in combination with two fundamental carbon nanoforms (carbon dots (CDs) and Hierarchical Porous Carbons (HPC)) for the preparation of intranasally (IN) administrated galantamine (GAL) nanoparticles (NPs). Initially, the modifi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571213/ https://www.ncbi.nlm.nih.gov/pubmed/36235952 http://dx.doi.org/10.3390/polym14194004 |
_version_ | 1784810308795105280 |
---|---|
author | Nanaki, Stavroula G. Spyrou, Konstantinos Veneti, Pelagia Karouta, Niki Gournis, Dimitrios Baroud, Turki N. Barmpalexis, Panagiotis Bikiaris, Dimitrios N. |
author_facet | Nanaki, Stavroula G. Spyrou, Konstantinos Veneti, Pelagia Karouta, Niki Gournis, Dimitrios Baroud, Turki N. Barmpalexis, Panagiotis Bikiaris, Dimitrios N. |
author_sort | Nanaki, Stavroula G. |
collection | PubMed |
description | The present study evaluates the use of thiolized chitosan conjugates (CS) in combination with two fundamental carbon nanoforms (carbon dots (CDs) and Hierarchical Porous Carbons (HPC)) for the preparation of intranasally (IN) administrated galantamine (GAL) nanoparticles (NPs). Initially, the modification of CS with L-cysteine (Cys) was performed, and the successful formation of a Cys-CS conjugates was verified via (1)H-NMR, FTIR, and pXRD. The new Cys-CS conjugate showed a significant solubility enhancement in neutral and alkaline pH, improving CS’s utility as a matrix-carrier for IN drug administration. In a further step, drug-loaded NPs were prepared via solid-oil–water double emulsification, and thoroughly analyzed by SEM, DLS, FTIR and pXRD. The results showed the formation of spherical NPs with a smooth surface, while the drug was amorphously dispersed within most of the prepared NPs, with the exemption of those systems contianing the CDs. Finally, in vitro dissolution release studies revealed that the prepared NPs could prolong GAL’s release for up to 12 days. In sum, regarding the most promising system, the results of the present study clearly suggest that the preparation of NPs using both Cys-CS and CDs results in a more thermodynamically stable drug dispersion, while a zero-order release profile was achieved, which is essential to attain a stable in vivo pharmacokinetic behavior. |
format | Online Article Text |
id | pubmed-9571213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95712132022-10-17 L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine Nanaki, Stavroula G. Spyrou, Konstantinos Veneti, Pelagia Karouta, Niki Gournis, Dimitrios Baroud, Turki N. Barmpalexis, Panagiotis Bikiaris, Dimitrios N. Polymers (Basel) Article The present study evaluates the use of thiolized chitosan conjugates (CS) in combination with two fundamental carbon nanoforms (carbon dots (CDs) and Hierarchical Porous Carbons (HPC)) for the preparation of intranasally (IN) administrated galantamine (GAL) nanoparticles (NPs). Initially, the modification of CS with L-cysteine (Cys) was performed, and the successful formation of a Cys-CS conjugates was verified via (1)H-NMR, FTIR, and pXRD. The new Cys-CS conjugate showed a significant solubility enhancement in neutral and alkaline pH, improving CS’s utility as a matrix-carrier for IN drug administration. In a further step, drug-loaded NPs were prepared via solid-oil–water double emulsification, and thoroughly analyzed by SEM, DLS, FTIR and pXRD. The results showed the formation of spherical NPs with a smooth surface, while the drug was amorphously dispersed within most of the prepared NPs, with the exemption of those systems contianing the CDs. Finally, in vitro dissolution release studies revealed that the prepared NPs could prolong GAL’s release for up to 12 days. In sum, regarding the most promising system, the results of the present study clearly suggest that the preparation of NPs using both Cys-CS and CDs results in a more thermodynamically stable drug dispersion, while a zero-order release profile was achieved, which is essential to attain a stable in vivo pharmacokinetic behavior. MDPI 2022-09-24 /pmc/articles/PMC9571213/ /pubmed/36235952 http://dx.doi.org/10.3390/polym14194004 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nanaki, Stavroula G. Spyrou, Konstantinos Veneti, Pelagia Karouta, Niki Gournis, Dimitrios Baroud, Turki N. Barmpalexis, Panagiotis Bikiaris, Dimitrios N. L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine |
title | L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine |
title_full | L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine |
title_fullStr | L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine |
title_full_unstemmed | L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine |
title_short | L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine |
title_sort | l-cysteine modified chitosan nanoparticles and carbon-based nanostructures for the intranasal delivery of galantamine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571213/ https://www.ncbi.nlm.nih.gov/pubmed/36235952 http://dx.doi.org/10.3390/polym14194004 |
work_keys_str_mv | AT nanakistavroulag lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine AT spyroukonstantinos lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine AT venetipelagia lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine AT karoutaniki lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine AT gournisdimitrios lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine AT baroudturkin lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine AT barmpalexispanagiotis lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine AT bikiarisdimitriosn lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine |